SEC 13F Intelligence

Managers / Q3 2020 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$179M
Q3 2020
Positions
21
Filings on Record
30
2019–present window
Filed
Nov 12, 2020
original filing

Summary

Maso Capital Partners Ltd reported $179M in U.S.-listed holdings across 21 positions for Q3 2020.

The portfolio is heavily concentrated: China Biologic Products alone accounts for 54.8% of reported value.

Compared with Q2 2020, the fund opened 10 new positions and exited 11.

Portfolio Metrics

Turnover
+19.6%
vs prior filed quarter
Top-10 Concentration
+91.5%
share of reported value
Largest Position
+54.8%
China Biologic Products
New / Exited
10 / 11
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Other: 63.3%Common Stock: 25.5%ADR: 9.8%GLOBAL: 1.3%ETP: 0.1%
  • Other · 63.3% · $113M
  • Common Stock · 25.5% · $46M
  • ADR · 9.8% · $18M
  • GLOBAL · 1.3% · $2M
  • ETP · 0.1% · $111,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ACIAACACIA COMMUNICATIONS INCNEW+100.0K100.0K+$7M$7M
SINA CORPNEW+150.0K150.0K+$6M$6M
ICLKGBPICLICK INTERACTIVE ASIA GROUP LTDNEW+679.5K679.5K+$5M$5M
DQDAQO NEW ENERGY CORPNEW+19.4K19.4K+$3M$3M
DOUYU INTERNATIONAL HOLDINGS LTDNEW+195.0K195.0K+$3M$3M
MOMO INCNEW+3.00M3.00M+$2M$2M
CLVTRIP.COM GROUP LTDNEW+50.0K50.0K+$2M$2M
PAASPAN AMERICAN SILVER CORPNEW+26.0K26.0K+$836,000$836,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

21 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CHINA BIOLOGIC PRODUCTS INCCOM54.82%$98M882.4K
2GNWGENWORTH FINANCIAL INChistory →COM CL A13.63%$24M7.28M
3ACIAACACIA COMMUNICATIONS INChistory →COM3.77%$7M100.0K
4SINA CORPORD3.57%$6M150.0K
5SOHUSOHU.COM INChistory →SPONSORED ADS3.19%$6M287.7K
6NEW FRONTIER HEALTH CORPORD SHS2.99%$5M700.0K
7ACHCACADIA HEALTHCARE CO INChistory →COM2.81%$5M170.3K
8ICLKGBPICLICK INTERACTIVE ASIA GROUP LTDhistory →SPONSORED ADR2.53%$5M679.5K
97HPHP INChistory →COM2.41%$4M227.4K
10TAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS1.75%$3M175.8K
11DQDAQO NEW ENERGY CORPhistory →SPNSRD ADR NEW1.47%$3M19.4K
12DOUYU INTERNATIONAL HOLDINGS LTDSPONSORED ADS1.44%$3M195.0K
13XRXXEROX HOLDINGS CORPhistory →COM NEW1.36%$2M129.9K
14MOMO INCNOTE1.31%$2M3.00M
15CLVTRIP.COM GROUP LTDADS0.87%$2M50.0K
16MRNAMODERNA INCCOM0.81%$1M20.4K
17PAASPAN AMERICAN SILVER CORPCOM0.47%$836,00026.0K
18DMY TECHNOLOGY GROUP INCCOM0.46%$829,00065.0K
19IPOAGBPVIRGIN GALACTIC HOLDINGS INCCOM0.27%$481,00025.0K
20SPDR S&P 500 ETF TRUSTTR UNIT0.06%$111,000331
21NAKED BRANDS GROUP INCSHS NEW0.00%$2,00021.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.